Clinical Trial

A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma

Study acronym: COMPAIR
Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the pharmacokinetics (PK) and safety of symbicort aerosphere and symbicort pressurized metered dose inhaler (pMDI) in participants with asthma aged 4 to less than 12 years.
Protocol Amendment History 5 changes
critical Trial completed 2026-07-16
notable Primary completion moved earlier: 2026-10-23 -> 2026-06-26 2026-07-16
minor Completion moved earlier: 2026-10-23 -> 2026-06-26 2026-07-16
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-27
notable Enrollment increased: 12 -> 15 participants 2026-05-27
Trial Details
NCT Number NCT07433569
Lead Sponsor AstraZeneca
Conditions Asthma
Enrollment 16 participants
Start Date 2026-03-05
Primary Completion 2026-06-26 (estimated)
Study Completion 2026-06-26 (estimated)
Updated on ClinicalTrials.gov 2026-07-15